Solid Tumor, Recurrent (DBCOND0076195)

Identifiers

Synonyms

Recurrent Solid Tumors / Recurrent Solid Tumor

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT02644460	Abemaciclib in Children With DIPG or Recurrent/Refractory Solid Tumors	Abemaciclib	treatment	1	completed
NCT06161493	ZEN003694 Combined With Niraparib in Patients With Metastatic or Recurrent Solid Tumors	Niraparib	treatment	1	withdrawn
NCT06031441	A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors	Atezolizumab	treatment	1	recruiting
NCT02261298	ONO-4538 Phase I Study in Patients With Solid Tumor	Nivolumab	treatment	1	completed
NCT03247309	TCR-engineered T Cells in Solid Tumors (ACTengine IMA201-101)	No drug interventions	treatment	1	completed
NCT00966498	Peripheral Blood Stem Cell Transplant (PBSCT) in Children With High Risk or Recurrent Solid Tumors	No drug interventions	treatment	Not Available	terminated
NCT02261285	ONO-4538 Phase I Study in Patients With Solid Tumor	Nivolumab	treatment	1	completed
NCT03096340	Safety and Pharmacokinetic Study of IT-141 in Monotherapy in Patients With Advanced Cancer	No drug interventions	treatment	1	terminated
NCT06238479	A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors	No drug interventions	treatment	1	recruiting
NCT06465069	A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors	No drug interventions	treatment	1	recruiting
NCT04901702	Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma	Irinotecan Talazoparib Temozolomide	treatment	1 / 2	active_not_recruiting
NCT02164097	ODSH + ICE Chemotherapy in Pediatric Solid Tumors	2-O, 3-O desulfated heparin	treatment	1	terminated
NCT06184035	A Dose Escalation and Expansion Study of [177Lu]Lu-SN201 in Participants With Advanced Cancer	Lutetium Lu-177	treatment	1 / 2	recruiting
NCT03374007	Phase I Clinical Trial in Chinese Patients of Advanced and (or) Recurrent Solid Tumor/Lymphoma	Geptanolimab	treatment	1	unknown_status
NCT04474470	A Study to Evaluate NT219 Alone and in Combination With ERBITUX® (Cetuximab) in Adults With Advanced Solid Tumors and Head and Neck Cancer	Cetuximab NT-219	treatment	1 / 2	active_not_recruiting